HR 1039
106th Congress
House
Taxation
Academic medical centers
Business income tax
Cancer research
Clinical trials
Commerce
Education
Foundations
Health
Higher education
Hospitals
Income tax
Medical research
Medical supplies
Orphan drugs
Pharmaceutical research
Research and development tax credit
Science, Technology, Communications
Social Welfare
Tax credits
To amend the Internal Revenue Code of 1986 to provide for a medical innovation tax credit for clinical testing research expenses attributable to academic medical centers and other qualified hospital research organizations.
Introduced: March 9, 1999
See on congress.gov
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Mar 9, 1999
Referred to the House Committee on Ways and Means.
Mar 9, 1999
Sponsor introductory remarks on measure. (CR E371-372)
Mar 9, 1999
Introduced in House
Plain-English summary
Amends the Internal Revenue Code to establish a limited credit for "qualified medical innovation expenses." Defines such expenses as amounts paid by a taxpayer to any qualified academic institution for clinical testing research activities.
What's happening now
Referred to the House Committee on Ways and Means.
Committees of jurisdiction
1